Mounjaro, the weight loss injection developed by pharmaceutical firm Lilly, is set to be prescribed on the NHS for the first time. Also known as tirzepatide, the drug will become available to around 220,000 people in England over the next three years, focusing on those with the "greatest need" for i...
Join the news democracy
Where your votes
decide the Top 100
Mounjaro, the weight loss injection developed by pharmaceutical firm Lilly, is set to be prescribed on the NHS for the first time.
Also known as tirzepatide, the drug will become available to around 220,000 people in England over the next three years, focusing on those with the "greatest need" for it.
Mounjaro weight loss jab available at GPs - to select few
NHS begins mass rollout of weight-loss jabs to patients in England
Weight-loss injections: How do drugs like Wegovy and Mounjaro work?
NHS changes weight loss jab rules as GPs prepare for Mounjaro demand
Poll: Should weight loss drugs be widely available on the NHS?
Weight-loss jabs linked to hundreds of life-threatening illness cases and 10 deaths
‘I was diagnosed with deadly condition after taking weight-loss jab offered on NHS’
